Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer

Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer

Endometrial cancer is a common gynecological cancer with a poor prognosis, mostly attributed to tumor metastasis. Epithelial–mesenchymal transition (EMT) can be mediated via transforming growth factor beta (TGF-β) signaling pathway, facilitating the ability of cancer cell invasion and migration. Iso...

Full description

Bibliographic Details
Main Authors: Hsin-Yuan Chen, Yi-Fen Chiang, Jia-Syuan Huang, Tsui-Chin Huang, Yin-Hwa Shih, Kai-Lee Wang, Mohamed Ali, Yong-Han Hong, Tzong-Ming Shieh, Shih-Min Hsia
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
endometrial cancer
isoliquiritigenin
epithelial–mesenchymal transition
transforming growth factor beta
metastasis
Online Access:https://www.mdpi.com/2072-6694/13/6/1236

Internet

https://www.mdpi.com/2072-6694/13/6/1236

Similar Items